|
Published in Volume
98, Issue 8 (October 15,1996)
J. Clin. Invest.
98(8):
1755-1761 (1996).
doi:10.1172/JCI118974.
Copyright ©
1996, The American Society for
Clinical Investigation.
Research Article
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.
G Velho,
K F Petersen,
G Perseghin,
J H Hwang,
D L Rothman,
M E Pueyo,
G W Cline,
P Froguel and
G I Shulman
INSERM U358, Hôpital Saint-Louis, Paris, France.
Published October 15,
1996
All glucokinase gene mutations identified to date have been localized to exons that are common to the pancreatic and hepatic isoforms of the enzyme. While impaired insulin secretion has been observed in glucokinase-deficient subjects the consequences of this mutation on hepatic glucose metabolism remain unknown. To examine this question hepatic glycogen concentration was measured in seven glucokinase-deficient subjects with normal glycosylated hemoglobin and 12 control subjects using 13C nuclear magnetic spectroscopy during a day in which three isocaloric mixed meals were ingested. The relative fluxes of the direct and indirect pathways of hepatic glycogen synthesis were also assessed using [1-13C]glucose in combination with acetaminophen to noninvasively sample the hepatic UDP-glucose pool. Average fasting hepatic glycogen content was similar in glucokinase-deficient and control subjects (279+/-20 vs 284+/-14 mM; mean+/-SEM), and increased in both groups after the meals with a continuous pattern throughout the day. However, the net increment in hepatic glycogen content after each meal was 30-60% lower in glucokinase-deficient than in the control subjects (breakfast, 46% lower, P < 0.02; lunch, 62% lower, P = 0.002; dinner; 30% lower, P = 0.04). The net increment over basal values 4 h after dinner was 105 +/-18 mM in glucokinase-deficient and 148+/-11 mM in control subjects (P = 0.04). In the 4 h after breakfast, flux through the gluconeogenic pathway relative to the direct pathway of hepatic glycogen synthesis was higher in glucokinase-deficient than in control subjects (50+/-2% vs 34+/-5%; P = 0.038). In conclusion glucokinase-deficient subjects have decreased net accumulation of hepatic glycogen and relatively augmented hepatic gluconeogenesis after meals. These results suggest that in addition to the altered beta cell function, abnormalities in liver glycogen metabolism play an important role in the pathogenesis of hyperglycemia in patients with glucokinase-deficient maturity onset diabetes of young.
|
|
Articles that cite this article:
Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen Robert M. O’doherty, Per B. Jensen, Paul Anderson, John G. Jones, Hal K. Berman, Denise Kearney, Christopher B. Newgard J Clin Invest 105(4):479. [CrossRef] Glucokinase activators in diabetes management Matthew Coghlan, Brendan Leighton Expert Opin Invest Drugs 17(2):145. [CrossRef] Glucokinase (GCK) mutations in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy Anna L. Gloyn Hum Mutat 22(5):353. [CrossRef] Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice T. Gorman, D. C. D. Hope, R. Brownlie, A. Yu, D. Gill, J. Löfvenmark, M. Wedin, R. M. Mayers, M. R. Snaith, D. M. Smith Diabetes Obes Metab 10(10):885. [CrossRef] Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats G J Coope, A M Atkinson, C Allott, D Mckerrecher, C Johnstone, K G Pike, P C Holme, H Vertigan, D Gill, M P Coghlan Br J Pharmacol 149(3):328. [CrossRef] Alessandro Doria, Nattachet Plengvidhya Curr Opin Clin Nutr Metab Care 7(4):203. [CrossRef]
Luc Tappy, Rene Chiolero, Mette Berger Curr Opin Clin Nutr Metab Care 2(2):161. [CrossRef]
PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance Sean M. Crosson, Ahmir Khan, John Printen, Jeffrey E. Pessin, Alan R. Saltiel J Clin Invest 111(9):1423. [CrossRef] Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks H. B. T. Christesen, K. Brusgaard, H. Beck nielsen, B. Brock jacobsen Clin Endocrinol (Oxf) 68(5):747. [CrossRef] Diagnosis and Management of Maturity-Onset Diabetes of the Young Jos?? Timsit, Christine Bellann??-chantelot, Dani??le Dubois-laforgue, Gilberto Velho Treat Endocrinol 4(1):9. [CrossRef] Genetic Basis of Type 2 Diabetes Mellitus Johanna K Wolford, Barbora Vozarova de courten Treat Endocrinol 3(4):257. [CrossRef] Genetic testing in maturity onset diabetes of the young (MODY): a new challenge for the diabetic clinic M. Shepherd, A.C. Sparkes, A.T. Hattersley Pract Diab Int 18(1):16. [CrossRef] Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis J. Radziuk, S. Pye Diabetes Metab Res Rev 17(4):250. [CrossRef] Genetic and clinical characteristics of maturity-onset diabetes of the young Fernando M. A. Giuffrida, Andre F. Reis Diabetes Obes Metab 7(4):318. [CrossRef] Molecular etiologies of mody and other early-onset forms of diabetes David Q. Shih, Markus Stoffel Curr Diab Rep 2(2):125. [CrossRef] Characterization of Hepatic Glucose Metabolism Disorder with the Progress of Diabetes in Male Spontaneously Diabetic Torii Rats Tomohiko Sasase, Katsuhiro Miyajima, Nobuhisa Ueda, Takeshi Ohta, Mutsuyoshi Matsushita, Hisayo Morinaga, Hiromi Yamamoto, Kaoru Sakata, Sumiaki Fukuda, Makoto Ito J Vet Med Sci 70(11):1239. [CrossRef] Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor R. Murphy, A. Tura, P. M. Clark, J. J. Holst, A. Mari, A. T. Hattersley Diabetologica 52(1):154. [CrossRef]
|